PNPriyanka R. Narayan

Priyanka R. Narayan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Priyanka R. Narayan has a total of 20 co-authors. Here are the top co-authors by number of shared publications:

  • Alpa Sidhu

    Division of Medical Genetics and Genomics, The Stead Family Department of Pediatrics University of Iowa Health Care Iowa City Iowa USA

    1 shared publication
  • Amy E. Roberts

    Department of Cardiology Boston Children's Hospital Boston Massachusetts USA

    1 shared publication
  • Christine Giummo

    Division of Clinical Genetics and Metabolism, Department of Pediatrics University of Vermont Medical Center Burlington Vermont USA

    1 shared publication
  • David D. Weaver

    Department of Medical and Molecular Genetics Indiana University School of Medicine Indianapolis Indiana USA

    1 shared publication
  • Divya Jayvas

    Division of Newborn Medicine, Department of Pediatrics Boston Children's Hospital Boston Massachusetts USA

    1 shared publication
  • Jaclyn Kotlarek

    Division of Medical Genetics and Genomics, The Stead Family Department of Pediatrics University of Iowa Health Care Iowa City Iowa USA

    1 shared publication

Latest Publications

  • Identifying the Potential Role of Missense KIRREL3 Variants in Neurodevelopmental Phenotypes: A Case Series

    by Priyanka R. Narayan, Sabah Sabir, Divya Jayvas, Ryan Doan, Qifei Li, Katherine J. Anderson, Sharon Chen, Marcia V. Felker, Marta Frigeni, Christine Giummo, et al.

    Neurodevelopmental disorders encompass a large group of conditions, many of which can be explained by genetic variants. KIRREL3 has previously been associated with neurodevelopmental disorders and is expressed in the developing human basal ganglia and amygdala. Through GeneMatcher, which allows clinicians, families, and researchers to share information about novel gene variants, and the Simons Foundation Powering Autism Research (SPARK) project, we identified 26 individuals with different rare missense variants in KIRREL3, which were predicted to be damaging based on their REVEL score. All probands had neurodevelopmental diagnoses including autism spectrum disorder, global developmental delay, intellectual disability, or a learning disability. A full review of previous publications identified 10 rare KIRREL3 missense variants in 13 individuals who had at least one diagnosis of an autism spectrum disorder or intellectual disability. These findings highlight the potential role of KIRREL3 missense variants in neurodevelopmental disorders, which warrants further study.